Laboratory News and Research

RSS

Salk researchers shed new light on specific mechanisms that activate oncogenes

Cancer, caused by abnormal overgrowth of cells, is the second-leading cause of death in the world. Researchers from the Salk Institute have zeroed in on specific mechanisms that activate oncogenes, which are altered genes that can cause normal cells to become cancer cells.

7 Dec 2022

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico.

7 Dec 2022

Researchers detect the Alongshan virus for the first time in Swiss ticks

The Alongshan virus was discovered in China only five years ago. Now researchers at the University of Zurich have found the novel virus for the first time in Swiss ticks.

7 Dec 2022

Researchers share results of MVA-BN-respiratory syncytial virus vaccine human challenge trial

Researchers reported the immunogenicity, efficacy, and safety of the MVA-BN (modified vaccinia Ankara-Bavarian Nordic)-RSV (respiratory syncytial virus) vaccine against RSV-A (RSV subtype A) Memphis 37b strain in a human challenge trial.

7 Dec 2022

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers from the University of Maine and University of Massachusetts Amherst have designed new liquid-coated air filters that allow for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.

7 Dec 2022

LabVantage Solutions Launches Version 8.8 of its Flagship LIMS Platform

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of version 8.8 of its industry-leading LabVantage LIMS platform.

From LabVantage Solutions 7 Dec 2022

Grenova Earns ISO 9001:2015 and ISO 13485:2016 Certification as Part of Its Mission to Manufacture Green Technology

Grenova, creator of the laboratory industry’s only patented technology for washing and reusing plastic consumables, announced today that it has earned ISO 9001:2015 and ISO 13485:2016 certification as part of the company’s mission to make laboratories around the world sustainable, resilient, cost-effective, and highly efficient.

From Grenova 7 Dec 2022

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Researchers evaluated the immunogenicity, boosting efficacy, and safety of single-dose and two-dose MVA-BN (modified vaccinia Ankara-Bavarian Nordic) vaccinations in comparison to replicating smallpox vaccines.

7 Dec 2022

Paxlovid has been free so far. Next year, sticker shock awaits.

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid.

7 Dec 2022

BGI Genomics and the University of Pécs launch a joint laboratory in Hungary

On November 29, 2022, BGI Genomics and the University of Pécs (UP) agreed to launch a joint laboratory in Hungary.

6 Dec 2022

Discovery of three new brain tumor subtypes could help to identify novel, effective therapies

Research lead by RCSI University of Medicine and Health Sciences has discovered three new subtypes of brain tumor which could help to identify new and effective therapies.

6 Dec 2022

Largest machine learning effort securely aggregates data from brain scans of glioblastoma patients

Researchers at Penn Medicine and Intel Corporation led the largest-to-date global machine learning effort to securely aggregate knowledge from brain scans of 6,314 glioblastoma (GBM) patients at 71 sites around the globe and develop a model that can enhance identification and prediction of boundaries in three tumor sub-compartments, without compromising patient privacy.

6 Dec 2022

The critical role of flow cytometry in CAR+ T-Cell trials

In this interview, Ryan Muise talks to AZoNetwork about the added value of using flow cytometry in CAR T-Cell clinical trials.

From Cerba Research 6 Dec 2022

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Scientists believe bats first transmitted SARS-CoV-2 to humans in December 2019, and while the virus has since evolved into several variants such as delta and omicron, a new study indicates the virus is still highly transmissible between mammals.

5 Dec 2022

Study estimates the epidemiological impact of a COVID-19 testing-related incident at a surge laboratory in the UK

Researchers investigated the epidemiological impact of an incident at a laboratory in the UK.

5 Dec 2022

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Researchers evaluate the efficacy and safety of an oral antimicrobial drug acoziborole in patients with human African trypanosomiasis.

4 Dec 2022

Managers express explicit and implicit bias toward others from marginalized groups, study finds

In a study that examined bias in the workplace, a University of Florida researcher found that those in management positions demonstrate explicit and implicit bias toward others from marginalized groups and often express more implicit bias than people who are not in management.

2 Dec 2022

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

In a new study, researchers assessed the neurodevelopment in preschool-aged Zika-exposed children without congenital Zika syndrome.

2 Dec 2022

Scaling up the production of customized immune cells for drug development and testing

To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells.

1 Dec 2022

Laboratory News and Research

Salk researchers shed new light on specific mechanisms that activate oncogenes

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Researchers detect the Alongshan virus for the first time in Swiss ticks

Researchers share results of MVA-BN-respiratory syncytial virus vaccine human challenge trial

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

LabVantage Solutions Launches Version 8.8 of its Flagship LIMS Platform

Grenova Earns ISO 9001:2015 and ISO 13485:2016 Certification as Part of Its Mission to Manufacture Green Technology

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Paxlovid has been free so far. Next year, sticker shock awaits.

BGI Genomics and the University of Pécs launch a joint laboratory in Hungary

Discovery of three new brain tumor subtypes could help to identify novel, effective therapies

Largest machine learning effort securely aggregates data from brain scans of glioblastoma patients

The critical role of flow cytometry in CAR+ T-Cell trials

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Study estimates the epidemiological impact of a COVID-19 testing-related incident at a surge laboratory in the UK

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Managers express explicit and implicit bias toward others from marginalized groups, study finds

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

Scaling up the production of customized immune cells for drug development and testing

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo